VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J906. A total of 4 filers reported holding VIKING THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $160,000 | +15.9% | 200 | 0.0% | 0.04% | -40.5% |
Q3 2019 | $138,000 | -16.9% | 200 | 0.0% | 0.07% | -64.6% |
Q2 2019 | $166,000 | -32.0% | 200 | -18.4% | 0.21% | +78.6% |
Q1 2019 | $244,000 | -61.4% | 245 | -99.7% | 0.12% | -15.8% |
Q4 2018 | $632,000 | -32.8% | 72,600 | +13344.4% | 0.14% | +15.8% |
Q3 2018 | $941,000 | -9.3% | 540 | -50.6% | 0.12% | -25.0% |
Q2 2018 | $1,038,000 | – | 1,094 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 245 | $244,000 | 0.12% |
BOOTHBAY FUND MANAGEMENT, LLC | 604 | $600,000 | 0.06% |
GROUP ONE TRADING, L.P. | 237,200 | $2,358,000 | 0.03% |
SIMPLEX TRADING, LLC | 2,473 | $2,458,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 7,300 | $73,000 | 0.00% |